Jalan R, Hayes P C
Department of Medicine, Royal Infirmary of Edinburgh, UK.
Aliment Pharmacol Ther. 1995 Jun;9(3):263-70. doi: 10.1111/j.1365-2036.1995.tb00380.x.
The search continues for a single reliable test of liver function that provides accurate prognostic information in chronic liver disease, in acute liver failure, and about graft function following orthotopic liver transplantation. Although transaminases, the commonly used markers of hepatocellular injury, have a high sensitivity in screening for liver disease, they do not provide any information about prognosis. Rational assessment of liver function using bilirubin, serum albumin and prothrombin-time is limited by the relative lack of sensitivity of these measurements and their inability to identify the functional reserve of the liver. Dynamic liver function tests are an improvement on the static tests but are generally cumbersome. The ideal liver function test would be cheap, easy to perform and analyse, safe, have a simple pharmacokinetic profile with minimal drug interactions, have a high predictive value and provide quick results. Numerous quantitative liver function tests have been developed and have shown promise in some studies. The aim of this review is to assess the place of these tests in the practical management of liver disease.
人们仍在继续寻找一种可靠的肝功能检测方法,以便为慢性肝病、急性肝衰竭以及原位肝移植后的移植物功能提供准确的预后信息。虽然转氨酶是常用的肝细胞损伤标志物,在筛查肝病时具有较高的敏感性,但它们无法提供任何预后信息。使用胆红素、血清白蛋白和凝血酶原时间对肝功能进行合理评估,受到这些测量方法相对缺乏敏感性以及无法识别肝脏功能储备能力的限制。动态肝功能检测是对静态检测的改进,但通常操作繁琐。理想的肝功能检测应具备价格低廉、易于操作和分析、安全、药代动力学特征简单且药物相互作用最小、预测价值高以及结果快速等特点。已经开发出了许多定量肝功能检测方法,并且在一些研究中显示出了前景。本综述的目的是评估这些检测方法在肝病实际管理中的地位。